BarnesR., HadleyH., DickA., JohnstonO., DexterJ.: Changes in grade and stage of recurrent bladder tumor. J. Urol., 118; 177 (1977).
2.
BrosmanS.A.: Experience with Bacillus Calmette-Guérin in patients with superficial bladder carcinoma. J. Urol., 128: 27–29 (1982).
3.
FerrariP., PollastriC.A., CastagnettiG., GrassiD., TavoniF., FerrariG., PalmieriB.: L'uso di citostatici per via endovescicale nella profilassi delle recidive dei tumori superficiali della vescica. Urologia, 56; 223–230 (1989).
4.
LammD.L.: Southwest Oncology Group. Comparison of BCG and Doxorubicyn in the treatment and prophylaxis of superficial bladder cancer. J. Urol., 137; 178–182 (1987).
5.
LutzeyerW., RubbenH., DahmH.: Prognostic parameters in superficial bladder cancer: An analysis of 315 cases. J. Urol., 127; 250–252 (1982).
6.
MishinaT., OdaK., MurataS.: Mitomycin C bladder instillation therapy for bladder tumors. J. Urol., 114; 217–219 (1975).
7.
MoralesA., EidingerD., BruceA.W.: Intracavitary Bacillus Calmette-Guérin in the treatment of superfical bladder tumors. J. Urol., 116; 180–183 (1976).
8.
PavoneMacaluso M., IngargiolaG.B.: Local chemotherapy in bladder cancer treatment. Oncology, 37; 71 (1980).
9.
SolowayM.S.: Rationale for intensive intravesical chemotherapy in superficial bladder cancer. J. Urol., 123; 461–466 (1980).
